Welcome to the e-CCO Library!

P0324: Lower Bone Mineral Density and alterations in bone biomarkers DKK-1x7x7x7 Sclerostinx7x7x7 and Periostin in individuals with Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Palatianoux7x7x7 M.(1)*;Tsentidisx7x7x7 C.(2);Tzouvalax7x7x7 M.(3);Papaconstantinoux7x7x7 I.(4);Vezakisx7x7x7 A.(4);Gourgiotisx7x7x7 D.(5);Marmarinosx7x7x7 A.(5);Karamanolis5x7x7x7 G.(6);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0325: Is the augmentation index a good marker of cardiovascular risk in Crohn's disease?
Year: 2025
Source: ECCO'25
Authors: Fissahx7x7x7 M.(1)*;Rechachx7x7x7 A.(1);Charifix7x7x7 M.(1);Menzoux7x7x7 F.(1);Djouhrix7x7x7 M.(1);Chibanex7x7x7 A.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0326: Environmental factorsx7x7x7 genetic predisposition and subclinical inflammation in the development of perinuclear-antineutrophil cytoplasmic antibody (P-ANCA)-positive ulcerative colitis: A European twin study
Year: 2025
Source: ECCO'25
Authors: Bergemalmx7x7x7 D.(1)*;Amcoffx7x7x7 K.(1);Pierikx7x7x7 M.J.(2);Colombelx7x7x7 J.F.(3);Vermeirex7x7x7 S.(4);Bodinx7x7x7 L.(5);Halfvarsonx7x7x7 J.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0327: Histologic remission predicts endoscopic remission in patients with ulcerative colitis
Year: 2025
Source: ECCO'25
Authors: Aouroudx7x7x7 H.(1)*;Lairanix7x7x7 F.E.(1);Aouroudx7x7x7 M.(1);Nacirx7x7x7 O.(1);Ait Erramix7x7x7 A.(1);Oubahax7x7x7 S.(1);Samlanix7x7x7 Z.(1);Kratix7x7x7 K.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0328: Faecal calprotectin and MRI are complementary tools for assessing treatment efficacy and predicting the risk of bowel damage progression in Crohn's disease: results of the IZNOGOUD study
Year: 2025
Source: ECCO'25
Authors: Buissonx7x7x7 A.(1)*;Guilmoteaux7x7x7 T.(1);Allimantx7x7x7 C.(2);Pereirax7x7x7 B.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0329: Clostridium difficile infection associates with the need for biologics: a retrospective long-term analysis in a cohort of 102 ibd patients.
Year: 2025
Source: ECCO'25
Authors: Spagnuolox7x7x7 R.(1)*;Scarlatax7x7x7 G.G.M.(1);Moranox7x7x7 D.(1);Imolettix7x7x7 F.(1);Suracix7x7x7 E.(2);Marascox7x7x7 R.(2);Imeneox7x7x7 M.G.(2);Paviax7x7x7 G.(3);Pantanellax7x7x7 M.(3);Calabrettax7x7x7 M.V.(3);Marasciox7x7x7 N.(3);Quirinox7x7x7 A.(3);Trecarichix7x7x7 E.M.(4);Russo x7x7x7 A.(4);Abenavolix7x7x7 L.(1);Materax7x7x7 G.(3);Luzzax7x7x7 F.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P032: Distinct immune cell trigger responses in Ulcerative Colitis – Results from an in vivo human intestinal injury model
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bronze, M.(1,2)*;Vilstrup Johansen, J.(3);Attauabi, M.(1);Tveiten Bjerrum, J.(1);Ramírez Galera, M.(2);Woetmann, A.(2);Benedict Seidelin, J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P032: Hepatocyte growth factor and MET in ulcerative colitis, novel drug targets impairing neutrophil recruitment?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Verstockt*1,2, M. Stakenborg2, W-J. Wollants2, G. Van Assche1,2, M. Ferrante1,2, S. Vermeire1,2, G. Matteoli2

Created: Friday, 22 February 2019, 9:41 AM
P032: Host transcriptome signatures in human fecal-washes predict histological remission in IBD patients
Year: 2022
Source: ECCO'22
Authors: Ungar, B.(1);Yavzori, M.(1);Fudim, E.(1);Picard, O.(1);Kopylov, U.(1);Eliakim, R.(1);Shouval, D.(2);Levin, Y.(3);Savidor, A.(3);Ben-Moshe, S.(4);Manco, R.(4);Dan, S.(4);Egozi, A.(4);Bahar Halpern, K.(4);Mayer, C.(5);Barshak, I.(5);Ben-Horin, S.(1);Itzkovitz, S.(4);
Created: Friday, 11 February 2022, 3:52 PM
P032: IFN-γ controls the immunomodulatory properties of bone marrow mesenchymal stem cells via a microRNA29a/STAT-3 dependent mechanism
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Oikonomopoulos*1, P. Lacey1, T. Tomakili1, D. Iliopoulos2, 
D. W. Hommes1

Created: Friday, 22 February 2019, 9:49 AM
P032: MiR-511 deficiency aggravates T cell transfer colitis in mice
Year: 2021
Source: ECCO'21 Virtual
Authors: Rahman, S.(1);Elfiky, A.(1);H.P. van Hamersveld, P.(1);Verseijden, C.(1);Welting, O.(1);L Meijer, S.(2);B.M. Hakvoort, T.(1);J. de Jonge, W.(1);E.M. Heinsbroek, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P032: The pharmacological profile of TOP1288, a narrow spectrum kinase inhibitor in clinical development as an anti-inflammatory treatment for ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Foster M.*1, Biancheri P.2, Fyfe M.1, MacDonald T.3, Rowley A.1, Sirohi S.1, Solanke Y.1, Webber S.1, Walshe C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P033 Combination of vedolizumab with tacrolimus is more efficient in reducing intestinal inflammation than vedolizumab alone in the DSS-induced acute colitis mouse model
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Manzini, K. Atrott, M. Schwarzfischer, A. Laimbacher, S. Lang, G. Rogler, M. Scharl, M.R. Spalinger

Created: Thursday, 30 January 2020, 10:12 AM
P0330: The diagnostic pathway of paediatric Inflammatory Bowel Disease in a Scottish regional centre beforex7x7x7 during and after the Covid Pandemic: Good access to endoscopy but MRI lagging behind
Year: 2025
Source: ECCO'25
Authors: Motionx7x7x7 J.(1)*;Kishorex7x7x7 S.(1);Hansenx7x7x7 R.(2);Stewartx7x7x7 C.(1);Watsonx7x7x7 R.(1);Langx7x7x7 S.(3);Chalmersx7x7x7 I.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0331: Insights from the Polish Registry of Microscopic Colitis. The Overlapping Symptoms of Microscopic Colitis and Irritable Bowel Syndrome.
Year: 2025
Source: ECCO'25
Authors: Bielski x7x7x7 A.(1)*;Marlicz x7x7x7 W.(2);Małecka-Wojciesko x7x7x7 E.(3);Reguła x7x7x7 J.(4);Mróz x7x7x7 A.(5);Zwolińska-Wcisło x7x7x7 M.(6);Waśko-Czopnik x7x7x7 D.(7);Eder x7x7x7 P.(8);Daniluk x7x7x7 J.(9);Rosołowski x7x7x7 M.(10);Rydzewska x7x7x7 G.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0332: Optimization and assessment of colonoscopy preparation in Inflammatory Bowel Disease: a comprehensive single-center analysis with focus on disease-specific factors
Year: 2025
Source: ECCO'25
Authors: Saidanix7x7x7 R.(1)*;Cherifx7x7x7 D.(1);Hassinex7x7x7 H.(1);Yacoubx7x7x7 H.(1);Debbabix7x7x7 H.(1);Kchirx7x7x7 H.(1);Maamourix7x7x7 N.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0333: Predictive factors for thiopurine treatment failure in anti-TNF naïve IBD patients: Insights from a tertiary care Hepato-Gastroenterology center experience
Year: 2025
Source: ECCO'25
Authors: Adamou Mainassrax7x7x7 F.(1)*;Hassinix7x7x7 A.(2);Essadi x7x7x7 B.(2);Koulalix7x7x7 H.(2);Elmqaddemx7x7x7 O.(2);Zazourx7x7x7 A.(2);Zahix7x7x7 I.(2);Kharrassex7x7x7 G.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0334: AGMB-129x7x7x7 an investigational ALK5 inhibitor for the treatment of Fibrostenosing Crohn’s Disease (FSCD)x7x7x7 shows gastrointestinal (GI) restricted pharmacokinetics (PK) and a favorable safety profile in healthy subjects
Year: 2025
Source: ECCO'25
Authors: Sáez-Borderíasx7x7x7 A.(1)*;Van Kaemx7x7x7 T.(2);Albertix7x7x7 J.(3);Stiersx7x7x7 P.J.(2);Sabadiex7x7x7 C.(4);Van Heeswijkx7x7x7 R.(4);Sensox7x7x7 T.(1);Pampínx7x7x7 B.(5);Bosserx7x7x7 R.(6);Wieselx7x7x7 P.(7);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0335: Development of an entrustable professional activity for intestinal ultrasound in North America
Year: 2025
Source: ECCO'25
Authors: Aronskyyx7x7x7 I.(1);Spencerx7x7x7 E.(2);Yenx7x7x7 E.(3);Chughx7x7x7 R.(4);Winterx7x7x7 M.(5);Jacobsx7x7x7 J.(6);Wahbehx7x7x7 G.(7);Debruynx7x7x7 J.(8)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0336: From inflammation to depression: key biomarkers for Inflammatory Bowel Disease-related Major Depressive Disorder
Year: 2025
Source: ECCO'25
Authors: Hux7x7x7 C.(1)*;Guox7x7x7 H.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session